Emily M. Leproust

2021

In 2021, Emily M. Leproust earned a total compensation of $1.3M as President, Chief Executive Officer and Chair at Twist Bioscience Corp, a 83% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$615,974
Salary$590,083
Other$75,536
Total$1,281,593

Leproust received $616K in non-equity incentive plan, accounting for 48% of the total pay in 2021.

Leproust also received $590.1K in salary and $75.5K in other compensation.

Rankings

In 2021, Emily M. Leproust's compensation ranked 7,871st out of 12,405 executives tracked by ExecPay. In other words, Leproust earned more than 36.5% of executives.

ClassificationRankingPercentile
All
7,871
out of 12,405
37th
Division
Manufacturing
3,476
out of 5,494
37th
Major group
Chemicals And Allied Products
1,548
out of 2,369
35th
Industry group
Drugs
1,376
out of 2,090
34th
Industry
Biological Products, Except Diagnostic Substances
312
out of 452
31st
Source: SEC filing on January 4, 2022.

Leproust's colleagues

We found four more compensation records of executives who worked with Emily M. Leproust at Twist Bioscience Corp in 2021.

2021

Patrick Weiss

Twist Bioscience Corp

Chief Operating Officer

2021

James Thorburn

Twist Bioscience Corp

Chief Financial Officer

2021

Patrick Finn

Twist Bioscience Corp

Chief Commercial Officer

2021

William Banyai

Twist Bioscience Corp

Senior Vice President of Advanced Development and General Manager of Data Storage

News

You may also like